Article
Human antibody cocktail deploys multiple functions to confer pan-ebolavirus protection
2018-08-20
Abstract excerpt
During the unprecedented 2013–2016 Ebola virus disease (EVD) epidemic in Western Africa and in its aftermath, the passive administration of monoclonal antibodies (mAbs) emerged as a promising treatment approach 1–7 . However, all antibody-based therapeutics currently in advanced development are specific for a single member of the Ebolavirus genus, Ebola virus (EBOV), and ineffective against divergent outbreak-ca...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d163d97a-b9dd-57c1-ada8-dcf7f4e605ee
- DOI
- 10.1101/395525
